Study of Aranesp to Treat Anemia in Prostate Cancer Patients.

NCT00245895 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer
Anemia

Interventions

DRUG: Aranesp

Sponsor

University of Washington

Collaborators

[object Object]